Ameritas Investment Partners Inc. Raises Stake in Kenvue Inc. $KVUE

Ameritas Investment Partners Inc. increased its stake in Kenvue Inc. (NYSE:KVUE) by 2.3% in the second quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 191,179 shares of the company’s stock after purchasing an additional 4,315 shares during the quarter. Ameritas Investment Partners Inc.’s holdings in Kenvue were worth $3,999,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also recently made changes to their positions in the company. Renaissance Capital LLC boosted its position in Kenvue by 8.3% during the second quarter. Renaissance Capital LLC now owns 629,177 shares of the company’s stock worth $13,169,000 after purchasing an additional 48,267 shares in the last quarter. Farther Finance Advisors LLC raised its stake in shares of Kenvue by 80.7% during the 2nd quarter. Farther Finance Advisors LLC now owns 36,196 shares of the company’s stock worth $758,000 after buying an additional 16,164 shares during the last quarter. Arlington Partners LLC acquired a new position in shares of Kenvue during the 2nd quarter worth $2,110,000. Cornell Pochily Investment Advisors Inc. boosted its position in shares of Kenvue by 144.6% in the 2nd quarter. Cornell Pochily Investment Advisors Inc. now owns 33,173 shares of the company’s stock worth $694,000 after buying an additional 19,609 shares in the last quarter. Finally, TrueMark Investments LLC grew its stake in Kenvue by 8.8% in the 2nd quarter. TrueMark Investments LLC now owns 229,648 shares of the company’s stock valued at $4,807,000 after acquiring an additional 18,623 shares during the last quarter. Institutional investors and hedge funds own 97.64% of the company’s stock.

Wall Street Analyst Weigh In

KVUE has been the subject of a number of research reports. Edward Jones cut shares of Kenvue from a “strong-buy” rating to a “hold” rating in a research report on Monday, November 3rd. Canaccord Genuity Group restated a “hold” rating and set a $15.00 price objective (down from $26.00) on shares of Kenvue in a research report on Wednesday, October 29th. JPMorgan Chase & Co. lowered their target price on Kenvue from $24.00 to $21.00 and set an “overweight” rating on the stock in a report on Friday, October 10th. UBS Group dropped their price target on Kenvue from $23.00 to $17.00 and set a “neutral” rating for the company in a research report on Wednesday, October 8th. Finally, Rothschild Redb upgraded Kenvue from a “hold” rating to a “strong-buy” rating in a research report on Friday, September 26th. One investment analyst has rated the stock with a Strong Buy rating, five have issued a Buy rating, twelve have assigned a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat.com, the company presently has a consensus rating of “Hold” and an average target price of $20.23.

Kenvue Price Performance

Shares of NYSE KVUE opened at $16.83 on Tuesday. The company has a debt-to-equity ratio of 0.66, a current ratio of 0.98 and a quick ratio of 0.69. Kenvue Inc. has a 1-year low of $14.02 and a 1-year high of $25.17. The company has a market capitalization of $32.24 billion, a price-to-earnings ratio of 22.44 and a beta of 0.71. The business has a 50-day moving average of $16.14 and a 200-day moving average of $19.72.

Kenvue (NYSE:KVUE) last issued its quarterly earnings data on Monday, November 3rd. The company reported $0.28 EPS for the quarter, topping analysts’ consensus estimates of $0.27 by $0.01. The firm had revenue of $3.76 billion for the quarter, compared to analyst estimates of $3.83 billion. Kenvue had a net margin of 9.55% and a return on equity of 20.02%. The firm’s revenue was down 3.5% compared to the same quarter last year. During the same quarter in the previous year, the business posted $0.28 EPS. Kenvue has set its FY 2025 guidance at 1.000-1.050 EPS. On average, equities analysts anticipate that Kenvue Inc. will post 1.14 EPS for the current fiscal year.

Kenvue Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Wednesday, November 26th. Stockholders of record on Wednesday, November 12th will be issued a dividend of $0.2075 per share. The ex-dividend date of this dividend is Wednesday, November 12th. This represents a $0.83 annualized dividend and a dividend yield of 4.9%. Kenvue’s payout ratio is 110.67%.

About Kenvue

Kenvue Inc operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee's, ORSLTM, Rhinocort, Calpol, and Zyrtec brands.